SLC26A5 Gene Deafness Autosomal Recessive Type 61 Genetic Test
Cost: AED 4400.0
Overview
The SLC26A5 gene is associated with a type of deafness known as autosomal recessive type 61. This genetic test aims to identify any mutations or variations in the SLC26A5 gene that may be causing or contributing to an individual’s deafness.
Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to undergoing the SLC26A5 gene deafness genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A12.
Test Details
The SLC26A5 gene is responsible for autosomal recessive type 61 deafness. This means that both copies of the gene, one from each parent, must have the gene mutation for the individual to be affected by the condition. NGS (Next-Generation Sequencing) genetic testing is utilized to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of SLC26A5 gene deafness, NGS genetic testing involves sequencing the SLC26A5 gene to detect any mutations or variations that may be contributing to the individual’s deafness. The identification of the specific genetic mutation or variation can aid in confirming a diagnosis of SLC26A5 gene deafness and provide valuable information for genetic counseling and potential treatment options.
Test Name | SLC26A5 Gene Deafness autosomal recessive type 61 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A12 |
Test Details |
The SLC26A5 gene is associated with a type of deafness known as autosomal recessive type 61. This means that the gene mutation needs to be present in both copies of the gene (one from each parent) for the individual to be affected by the condition. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of SLC26A5 gene deafness, an NGS genetic test would involve sequencing the SLC26A5 gene to look for any mutations or variations that may be causing or contributing to the individual’s deafness. By identifying the specific genetic mutation or variation, NGS genetic testing can help in confirming a diagnosis of SLC26A5 gene deafness and provide valuable information for genetic counseling and potential treatment options. |